nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Aphasia—Isotretinoin—peripheral nervous system neoplasm	0.0205	0.0205	CcSEcCtD
Gadobutrol—Pregnancy—Alitretinoin—peripheral nervous system neoplasm	0.0178	0.0178	CcSEcCtD
Gadobutrol—Aphasia—Alitretinoin—peripheral nervous system neoplasm	0.0156	0.0156	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Topotecan—peripheral nervous system neoplasm	0.0101	0.0101	CcSEcCtD
Gadobutrol—Sweating increased—Tretinoin—peripheral nervous system neoplasm	0.00814	0.00814	CcSEcCtD
Gadobutrol—Sweating increased—Isotretinoin—peripheral nervous system neoplasm	0.00814	0.00814	CcSEcCtD
Gadobutrol—Urine abnormality—Epirubicin—peripheral nervous system neoplasm	0.00798	0.00798	CcSEcCtD
Gadobutrol—Pollakiuria—Tretinoin—peripheral nervous system neoplasm	0.00772	0.00772	CcSEcCtD
Gadobutrol—Pollakiuria—Isotretinoin—peripheral nervous system neoplasm	0.00772	0.00772	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Epirubicin—peripheral nervous system neoplasm	0.00751	0.00751	CcSEcCtD
Gadobutrol—Urine abnormality—Doxorubicin—peripheral nervous system neoplasm	0.00738	0.00738	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00695	0.00695	CcSEcCtD
Gadobutrol—Parosmia—Epirubicin—peripheral nervous system neoplasm	0.00681	0.00681	CcSEcCtD
Gadobutrol—Hypoaesthesia—Topotecan—peripheral nervous system neoplasm	0.00671	0.00671	CcSEcCtD
Gadobutrol—Hypoaesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00665	0.00665	CcSEcCtD
Gadobutrol—Hypoaesthesia—Tretinoin—peripheral nervous system neoplasm	0.00665	0.00665	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.00645	0.00645	CcSEcCtD
Gadobutrol—Visual impairment—Tretinoin—peripheral nervous system neoplasm	0.00644	0.00644	CcSEcCtD
Gadobutrol—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.00644	0.00644	CcSEcCtD
Gadobutrol—Parosmia—Doxorubicin—peripheral nervous system neoplasm	0.0063	0.0063	CcSEcCtD
Gadobutrol—Sweating increased—Alitretinoin—peripheral nervous system neoplasm	0.00617	0.00617	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.00591	0.00591	CcSEcCtD
Gadobutrol—Pollakiuria—Alitretinoin—peripheral nervous system neoplasm	0.00585	0.00585	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Cisplatin—peripheral nervous system neoplasm	0.0057	0.0057	CcSEcCtD
Gadobutrol—Injection site pain—Epirubicin—peripheral nervous system neoplasm	0.00541	0.00541	CcSEcCtD
Gadobutrol—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.00525	0.00525	CcSEcCtD
Gadobutrol—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00514	0.00514	CcSEcCtD
Gadobutrol—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00514	0.00514	CcSEcCtD
Gadobutrol—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00504	0.00504	CcSEcCtD
Gadobutrol—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00504	0.00504	CcSEcCtD
Gadobutrol—Hypoaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00504	0.00504	CcSEcCtD
Gadobutrol—Injection site pain—Doxorubicin—peripheral nervous system neoplasm	0.005	0.005	CcSEcCtD
Gadobutrol—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00498	0.00498	CcSEcCtD
Gadobutrol—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.00488	0.00488	CcSEcCtD
Gadobutrol—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.00486	0.00486	CcSEcCtD
Gadobutrol—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00485	0.00485	CcSEcCtD
Gadobutrol—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00485	0.00485	CcSEcCtD
Gadobutrol—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.00481	0.00481	CcSEcCtD
Gadobutrol—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00479	0.00479	CcSEcCtD
Gadobutrol—Infection—Topotecan—peripheral nervous system neoplasm	0.00476	0.00476	CcSEcCtD
Gadobutrol—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00475	0.00475	CcSEcCtD
Gadobutrol—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00475	0.00475	CcSEcCtD
Gadobutrol—Infection—Tretinoin—peripheral nervous system neoplasm	0.00472	0.00472	CcSEcCtD
Gadobutrol—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00472	0.00472	CcSEcCtD
Gadobutrol—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00469	0.00469	CcSEcCtD
Gadobutrol—Infection—Melphalan—peripheral nervous system neoplasm	0.00466	0.00466	CcSEcCtD
Gadobutrol—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00463	0.00463	CcSEcCtD
Gadobutrol—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00459	0.00459	CcSEcCtD
Gadobutrol—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00459	0.00459	CcSEcCtD
Gadobutrol—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.0043	0.0043	CcSEcCtD
Gadobutrol—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.0043	0.0043	CcSEcCtD
Gadobutrol—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.0043	0.0043	CcSEcCtD
Gadobutrol—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Gadobutrol—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Gadobutrol—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Gadobutrol—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00424	0.00424	CcSEcCtD
Gadobutrol—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00424	0.00424	CcSEcCtD
Gadobutrol—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00421	0.00421	CcSEcCtD
Gadobutrol—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00418	0.00418	CcSEcCtD
Gadobutrol—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00416	0.00416	CcSEcCtD
Gadobutrol—Pain—Topotecan—peripheral nervous system neoplasm	0.0041	0.0041	CcSEcCtD
Gadobutrol—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00406	0.00406	CcSEcCtD
Gadobutrol—Pain—Tretinoin—peripheral nervous system neoplasm	0.00406	0.00406	CcSEcCtD
Gadobutrol—Pain—Melphalan—peripheral nervous system neoplasm	0.00401	0.00401	CcSEcCtD
Gadobutrol—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00394	0.00394	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00392	0.00392	CcSEcCtD
Gadobutrol—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.0039	0.0039	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00388	0.00388	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00388	0.00388	CcSEcCtD
Gadobutrol—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00386	0.00386	CcSEcCtD
Gadobutrol—Abnormal vision—Epirubicin—peripheral nervous system neoplasm	0.00385	0.00385	CcSEcCtD
Gadobutrol—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00382	0.00382	CcSEcCtD
Gadobutrol—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00382	0.00382	CcSEcCtD
Gadobutrol—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00379	0.00379	CcSEcCtD
Gadobutrol—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00379	0.00379	CcSEcCtD
Gadobutrol—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Gadobutrol—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Gadobutrol—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Gadobutrol—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Gadobutrol—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Gadobutrol—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00367	0.00367	CcSEcCtD
Gadobutrol—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Gadobutrol—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Gadobutrol—Abnormal vision—Doxorubicin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Gadobutrol—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00353	0.00353	CcSEcCtD
Gadobutrol—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.0035	0.0035	CcSEcCtD
Gadobutrol—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.0035	0.0035	CcSEcCtD
Gadobutrol—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Gadobutrol—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00347	0.00347	CcSEcCtD
Gadobutrol—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Gadobutrol—Infection—Vincristine—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Gadobutrol—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Gadobutrol—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.0034	0.0034	CcSEcCtD
Gadobutrol—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Gadobutrol—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00335	0.00335	CcSEcCtD
Gadobutrol—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Gadobutrol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Gadobutrol—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Gadobutrol—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Gadobutrol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Gadobutrol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Gadobutrol—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Gadobutrol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Gadobutrol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Gadobutrol—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Gadobutrol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Gadobutrol—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Gadobutrol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Gadobutrol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Gadobutrol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Gadobutrol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Gadobutrol—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Gadobutrol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Gadobutrol—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Gadobutrol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Gadobutrol—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Gadobutrol—Infection—Cisplatin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Gadobutrol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Gadobutrol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Gadobutrol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Gadobutrol—Rash—Topotecan—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Gadobutrol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Gadobutrol—Headache—Topotecan—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Gadobutrol—Rash—Tretinoin—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Gadobutrol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Gadobutrol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Gadobutrol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Gadobutrol—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Gadobutrol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Gadobutrol—Headache—Tretinoin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Gadobutrol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Gadobutrol—Pain—Vincristine—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Gadobutrol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Gadobutrol—Rash—Melphalan—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Gadobutrol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Gadobutrol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Gadobutrol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Gadobutrol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Gadobutrol—Nausea—Topotecan—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Gadobutrol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Gadobutrol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Gadobutrol—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Gadobutrol—Infection—Etoposide—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Gadobutrol—Nausea—Melphalan—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Gadobutrol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Gadobutrol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Gadobutrol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Gadobutrol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Gadobutrol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Gadobutrol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Gadobutrol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Gadobutrol—Pain—Cisplatin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Gadobutrol—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Gadobutrol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Gadobutrol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Gadobutrol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Gadobutrol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Gadobutrol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Gadobutrol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Gadobutrol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Gadobutrol—Pain—Etoposide—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Gadobutrol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Gadobutrol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Gadobutrol—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Gadobutrol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Gadobutrol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Gadobutrol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Gadobutrol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Gadobutrol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Gadobutrol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Gadobutrol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Gadobutrol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Gadobutrol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Gadobutrol—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Gadobutrol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Gadobutrol—Rash—Vincristine—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Gadobutrol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Gadobutrol—Headache—Vincristine—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Gadobutrol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Gadobutrol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Gadobutrol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Gadobutrol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Gadobutrol—Nausea—Vincristine—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Gadobutrol—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Gadobutrol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Gadobutrol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Gadobutrol—Rash—Cisplatin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Gadobutrol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Gadobutrol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Gadobutrol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Gadobutrol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Gadobutrol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Gadobutrol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Gadobutrol—Rash—Etoposide—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Gadobutrol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Gadobutrol—Headache—Etoposide—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Gadobutrol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Gadobutrol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Gadobutrol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Gadobutrol—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Gadobutrol—Nausea—Etoposide—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Gadobutrol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Gadobutrol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Gadobutrol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Gadobutrol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Gadobutrol—Infection—Epirubicin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Gadobutrol—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Gadobutrol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gadobutrol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Gadobutrol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Gadobutrol—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Gadobutrol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Gadobutrol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Gadobutrol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Gadobutrol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Gadobutrol—Pain—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Gadobutrol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Gadobutrol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Gadobutrol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Gadobutrol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Gadobutrol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Gadobutrol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Gadobutrol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Gadobutrol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Gadobutrol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Gadobutrol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Gadobutrol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Gadobutrol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Gadobutrol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Gadobutrol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000997	0.000997	CcSEcCtD
Gadobutrol—Rash—Epirubicin—peripheral nervous system neoplasm	0.000993	0.000993	CcSEcCtD
Gadobutrol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000992	0.000992	CcSEcCtD
Gadobutrol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000987	0.000987	CcSEcCtD
Gadobutrol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000964	0.000964	CcSEcCtD
Gadobutrol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000936	0.000936	CcSEcCtD
Gadobutrol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Gadobutrol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000919	0.000919	CcSEcCtD
Gadobutrol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000918	0.000918	CcSEcCtD
Gadobutrol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000913	0.000913	CcSEcCtD
Gadobutrol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000866	0.000866	CcSEcCtD
